FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Imprimis NJOF MYDRIATIC-4: Tropicamide Recall

MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic…

Imprimis NJOF, LLC · Ledgewood, NJ

Risk level
Class III
Reported by FDA
Oct 25, 2023
Recall ID
D-0043-2024
Check your lot numberHow we source this data

Summary

Imprimis NJOF recalled MYDRIATIC-4: Tropicamide starting Sep 20, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0043-2024 on Oct 25, 2023. Reason: Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim. Status: Terminated.

Why it was recalled

Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.

Product description

MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle, Imprimis, NJOF, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC:71384-632-05

Lot numbers, UPCs & expiration codes

Lot#s: 22DEC065 (MDU), exp: 09/29/2023; 23JAN024 (MDU), exp: 10/13/2023; 23FEB024 (SDU), exp: 11/09/2023; 23MAR013 (SDU), exp: 12/01/2023; 23MAR033 (SDU), exp: 12/16/2023; 23MAY044 (SDU), exp: 03/23/2024;

Where it was sold

Product was distributed to physician's offices nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0043-2024
Classification
Class III
Status
Terminated
Recall initiated
Sep 20, 2023
FDA report date
Oct 25, 2023
Quantity
6,228 bags + 15,360 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Imprimis NJOF, LLC

Original FDA data

Every field from FDA enforcement report D-0043-2024, exactly as published.

Show all FDA fields
City
Ledgewood
State
NJ
Status
Terminated
Country
United States
Event ID
93093
Address
1705 Route 46 Ste 6B
Code information
Lot#s: 22DEC065 (MDU), exp: 09/29/2023; 23JAN024 (MDU), exp: 10/13/2023; 23FEB024 (SDU), exp: 11/09/2023; 23MAR013 (SDU), exp: 12/01/2023; 23MAR033 (SDU), exp: 12/16/2023; 23MAY044 (SDU), exp: 03/23/2024;
Postal code
07852-9720
Report date
Oct 25, 2023
Product type
Drugs
Recall number
D-0043-2024
Classification
Class III
Recalling firm
Imprimis NJOF, LLC
Product quantity
6,228 bags + 15,360 boxes
Termination date
Jul 17, 2025
Reason for recall
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
Voluntary / mandated
Voluntary: Firm initiated
Product description
MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle, Imprimis, NJOF, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC:71384-632-05
Distribution pattern
Product was distributed to physician's offices nationwide.
Recall initiation date
Sep 20, 2023
Initial firm notification
Letter
Center classification date
Oct 13, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0043-2024, published Oct 25, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls